Please Upload related files below
Fill in below.
Tell us the stocks you own using Snaptrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. Snaptrade only shares the tickers you own and your transaction history, not your account numbers. Using Snaptrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery- link your account with Snaptrade.
On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates. Additionally, the Company reported Patient Direct revenue that was below expectations. Management blamed it on “unique challenges that occurred in the quarter.” Analysts commenting on the missed revenue noted 2024 may be even more back-half weighted than management already guided.
Following this news, Owens’s stock price fell by $6.30 per share, or approximately 26% to close at $18.21 per share.